AM, A., LS, B., I, A., & A, J. (2026). Clinical pathway implementation for adult sickle cell vaso-occlusive crises: Impact on healthcare utilization, opioid prescribing, and costs. Annals of Saudi medicine, 46(5), 319. https://doi.org/10.5144/0256-4947.2026.319
Chicago Style (17th ed.) CitationAM, Alhartani, Binmahfouz LS, Alhazmi I, and Jambi A. "Clinical Pathway Implementation for Adult Sickle Cell Vaso-occlusive Crises: Impact on Healthcare Utilization, Opioid Prescribing, and Costs." Annals of Saudi Medicine 46, no. 5 (2026): 319. https://doi.org/10.5144/0256-4947.2026.319.
MLA (9th ed.) CitationAM, Alhartani, et al. "Clinical Pathway Implementation for Adult Sickle Cell Vaso-occlusive Crises: Impact on Healthcare Utilization, Opioid Prescribing, and Costs." Annals of Saudi Medicine, vol. 46, no. 5, 2026, p. 319, https://doi.org/10.5144/0256-4947.2026.319.